FAX: 212.655.1763
New York
30 Rockefeller Plaza
24th Floor
New York, NY 10112
Practices
Industries
Blaine Templeman
Print PDFPartner
Mr. Templeman is a partner in the Corporate and Intellectual Property Practice Groups (IP Transactions) in the firm's New York office. He serves as co-leader of the firm's Life Sciences group.
Areas of Practice
Mr. Templeman’s practice is focused on counseling U.S. and international clients in the protection and development of their products and IP portfolios through domestic and cross-border intellectual property transactions, manufacturing, clinical trials, outsourcing, research, and contracting.
As part of his efforts to protect and preserve the value of his clients' companies, Mr. Templeman leads the firm’s Clinical Contracting Team, which services clients’ needs with respect to confidentiality agreements, clinical trials agreements, CRO agreements, master service agreements, laboratory agreements, manufacturing agreements (including product development, API and finished product agreements), research arrangements and other similar agreements. He has completed clinical trials arrangements with hundreds of clinical sites around the world. He has also worked closely with several of his clients to complete transactions in the US, EU, Russia, Israel, Lebanon, Australia, New Zealand, India, Japan, Korea, Taiwan, Brazil, Argentina, Peru, Mexico, Guatemala and many other countries.
His transactional work includes mergers and acquisitions, asset deals, collaborations, licensing transactions, distribution arrangements and copromotions. He assists clients in a variety of industries including (among many others) oncology treatments, vaccines, antibiotics, diabetes treatments, anti-fungals, sexual dysfunction treatments and medical devices.
Mr. Templeman has assisted his clients in several ways:
- advising a contract manufacturer on supply arrangements with a large pharmaceutical company
- assisting a client in analyzing changing contract terms and risks for blockbuster drug coming off patent;
- assisting a French client in outlicensing for North America a beta lactamase inhibitor to a US pharma company;
- counseling a client and preparing client's response and related documents and releases in reaction to possible mass HCV infection at a clinical site;
- preparing a client for potential litigation by reviewing pertinent documents, considering potential claims and setting up policies for internal communication and public response after several adverse events in a worldwide trial;
- helping a US client purchase US rights to an oncology treatment;
- setting up worldwide development and distribution arrangements including in the US , EU, Korea , and Russia;
- assisting a prominent Indian client with investments and collaborations with US companies;
- negotiating dispute resolutions when clinical trials are not being executed efficiently; and
- negotiating manufacturing arrangements with contract manufacturers for API, finished product, drug delivery systems, medical devices and equipment.
Mr. Templeman is one of only 6 attorneys in the NY area that have been named a Best Lawyer in America for Biotechnology Law.
Education
- J.D., New York University School of Law, 1994
- Princeton Seminary, 1988-89 (M.Div. Program Candidate)
- B.A., Oral Roberts University, 1988, summa cum laude
Admissions
- New York